InvestorsHub Logo
Followers 75
Posts 9162
Boards Moderated 0
Alias Born 04/25/2002

Re: medicinecat post# 36333

Thursday, 11/02/2023 9:32:33 PM

Thursday, November 02, 2023 9:32:33 PM

Post# of 36559
It will be an R/S. That will regenerate the cash flow to keep financing the salaries and bonuses. It is what it is. Unfortunately this was simply an EUA dream, just like so many other tiny biotech during the COVID era. I got a burned a bit by the the same dream with RLFTF. They did the nasty R/S (1 for 400), which wiped the SH out. Ouch. Of course they sold the R/S with PRs that it was to get to the NASDAQ, which never happened. It's SOP in the pennyworld.